Dr. Sarah A. Holstein, MD

Dr. Holstein practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Holstein's NPI, 1235349275, was assigned on May 22, 2007. Dr. Holstein graduated from University of Iowa, RJ & L Carver College of Medicine in 2004. Dr. Holstein holds Nebraska license 29342.

Dr. Holstein's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Holstein also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Holstein's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Holstein is also affiliated with Bryan Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Holstein to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holstein practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Holstein's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Holstein is licensed in Nebraska.

CMS data shows 1,485 Medicare services from Dr. Holstein across 4 procedure codes in 2024, for 210 Medicare patients. Medicare paid $63,306 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Dr. Holstein in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 64% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Holstein's median patient age at 72, with 49% women.

In 2024, Dr. Holstein wrote 1,425 Medicare Part D claims for 94 patients. 48% of them were for generic drugs. CMS names the drug for 1,299 of them, across 23 drugs with 11 or more claims each, at $8,208,026 in total drug cost. In 2023, CMS named 1,167 claims across 20 drugs.

Dr. Holstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holstein as offering telehealth.

CMS Open Payments shows 85 general payments to Dr. Holstein from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Celgene Corporation paid the most, $54,712. It also lists 3 research payments totaling $70,548 from 2016 to 2025.

Dr. Holstein graduated from University of Iowa, RJ & L Carver College of Medicine in 2004.